About the Authors

Peter J. Hotez

hotez@bcm.edu (PJH); bottazzi@bcm.edu (MEB)

Affiliations Texas Children’s Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America, Department of Biology, Baylor University, Waco, Texas, United States of America, Hagler Institute for Advanced Study at Texas A&M University, and Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, Texas, United States of America, James A. Baker III Institute of Public Policy, Rice University, Houston, Texas, United States of America

Maria Elena Bottazzi

hotez@bcm.edu (PJH); bottazzi@bcm.edu (MEB)

Affiliations Texas Children’s Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America, Department of Biology, Baylor University, Waco, Texas, United States of America

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: The authors have developed subunit vaccines against SARS and MERS coronavirus infections. They are involved in the process of developing a vaccine against SARS-CoV-2.